This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Moderna Inc. slipped 4.2% to $26.12 on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index falling 0.8% to 19,298.45 and Dow Jones Industrial Average falling 0.3% to 42,319.74.
This was the stock's second consecutive day of losses.
Moderna Inc. closed 83.6% short of its 52-week high of $158.82, which the company achieved on June 6th.
The stock underperformed when compared to some of its competitors, as Johnson & Johnson rose 0.3% to $153.66, Pfizer Inc. fell 1.2% to $23.12, and Gilead Sciences Inc. rose 1.32% to $110.46.
Trading volume totaled 9.8 million, compared to the 50-day average of 11.4 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
June 05, 2025 16:34 ET (20:34 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.